HIF-1-Dependent Reprogramming of Glucose Metabolic Pathway of Cancer Cells and Its Therapeutic Significance.

Nagao A, Kobayashi M, Koyasu S, Chow CCT, Harada H. · 2019

Read HIF-1-Dependent Reprogramming of Glucose Metabolic Pathway of Cancer Cells and Its Therapeutic Significance. by Nagao A, Kobayashi M, Koyasu S, Chow CCT, Harada H. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6359724.txt.

Description

Nagao and co-authors present a review in the International Journal of Molecular Sciences on how cancer cells rewire glucose use. The focus is HIF-1, a protein that helps cells respond to low oxygen. The authors explain how HIF-1 drives the Warburg effect, where tumors favor fast glycolysis even when oxygen is present.

The review covers how HIF-1 turns on glycolysis and a linked pathway that supplies building blocks for growth. It also links this metabolic shift to antioxidant defenses and resistance to radiation. The authors add their own findings on a factor that raises HIF-1 activity in cancer cells. Readers get a clear map of these pathways and of possible treatment targets.

Catalog record

CREATORNagao A, Kobayashi M, Koyasu S, Chow CCT, Harada H.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE37 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6359724

Browse the full library · About the Tower of Babel